Huntington disease-like syndrome due to C9ORF72 expansions: A Patient Guide

• It explains a genetic susceptibility: The expansion places you in a disease spectrum linked to C9ORF72.
• It does NOT predict a single future syndrome: While symptoms can span movement, cognitive, and motor-neuron domains, having the expansion does not mean ALS, FTD, or dementia is inevitable. Your disease course is highly individual.

Receiving a diagnosis of Huntington disease-like syndrome due to C9ORF72 expansions often marks the end of a long and confusing search for answers. For many families, the journey begins with symptoms that look exactly like classic Huntington’s disease—such as involuntary movements, mood shifts, or changes in thinking—only to have the standard genetic tests for that condition come back negative. This clinical presentation is why doctors call the condition an HD phenocopy: it acts like Huntington’s on the surface, but its biological cause is different ^[1].

The root cause of this condition is a specific sequence change in the C9ORF72 gene, known as a hexanucleotide repeat expansion. While everyone has a small number of these genetic repeats, people with this syndrome have a significantly expanded number, which alters the gene’s function. This expansion is an important genetic cause of two other major conditions: Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Because of this biological link, a patient’s symptoms can span three different domains: the movement issues seen in Huntington’s, the personality and behavioral changes seen in FTD, and the muscle weakness seen in ALS ^[2]. However, many carriers do not develop all three domains; these are possible associations, not a strict forecast.

Identifying this specific variant requires specialized tools. Standard genetic sequencing often misses these massive repeats, so doctors must use a technique called repeat-primed PCR to confirm the diagnosis. Once identified, care shifts to a multidisciplinary approach. Because the disease can change over time—perhaps starting with movement issues and later affecting breathing or memory—it is managed by a team of specialists, including neurologists, speech therapists, and respiratory experts, who work together to address each symptom as it arises ^[3].

This diagnosis also carries deep implications for the entire family. Because the gene is autosomal dominant, it can be passed from parent to child, but it behaves with variable expressivity. This means that while one person in a family may have an HD-like syndrome, a relative who inherits the same gene might develop ALS, FTD, an overlap syndrome, or no symptoms at all. Navigating these risks requires the support of a genetic counselor who can help relatives make informed decisions about their own health. While the complexity of this spectrum can be daunting, a clear diagnosis provides a roadmap for individualized proactive care and connects families to a growing field of research dedicated to this specific genetic expansion ^[4].